Cargando…
Fertility preservation in female classic galactosemia patients
Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI) as a diet-independent complication of the disease. This is a major concern for patients and their parents, and physicians are often asked about possible options to preserve fertility. Unfortunately, there a...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718676/ https://www.ncbi.nlm.nih.gov/pubmed/23866841 http://dx.doi.org/10.1186/1750-1172-8-107 |
_version_ | 1782277800891252736 |
---|---|
author | van Erven, Britt Gubbels, Cynthia S van Golde, Ron J Dunselman, Gerard A Derhaag, Josien G de Wert, Guido Geraedts, Joep P Bosch, Annet M Treacy, Eileen P Welt, Corrine K Berry, Gerard T Rubio-Gozalbo, M Estela |
author_facet | van Erven, Britt Gubbels, Cynthia S van Golde, Ron J Dunselman, Gerard A Derhaag, Josien G de Wert, Guido Geraedts, Joep P Bosch, Annet M Treacy, Eileen P Welt, Corrine K Berry, Gerard T Rubio-Gozalbo, M Estela |
author_sort | van Erven, Britt |
collection | PubMed |
description | Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI) as a diet-independent complication of the disease. This is a major concern for patients and their parents, and physicians are often asked about possible options to preserve fertility. Unfortunately, there are no recommendations on fertility preservation in this group. The unique pathophysiology of classic galactosemia with a severely reduced follicle pool at an early age requires an adjusted approach. In this article recommendations for physicians based on current knowledge concerning galactosemia and fertility preservation are made. Fertility preservation is only likely to be successful in very young prepubertal patients. In this group, cryopreservation of ovarian tissue is currently the only available technique. However, this technique is not ready for clinical application, it is considered experimental and reduces the ovarian reserve. Fertility preservation at an early age also raises ethical questions that should be taken into account. In addition, spontaneous conception despite POI is well described in classic galactosemia. The uncertainty surrounding fertility preservation and the significant chance of spontaneous pregnancy warrant counseling towards conservative application of these techniques. We propose that fertility preservation should only be offered with appropriate institutional research ethics approval to classic galactosemia girls at a young prepubertal age. |
format | Online Article Text |
id | pubmed-3718676 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37186762013-07-23 Fertility preservation in female classic galactosemia patients van Erven, Britt Gubbels, Cynthia S van Golde, Ron J Dunselman, Gerard A Derhaag, Josien G de Wert, Guido Geraedts, Joep P Bosch, Annet M Treacy, Eileen P Welt, Corrine K Berry, Gerard T Rubio-Gozalbo, M Estela Orphanet J Rare Dis Review Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI) as a diet-independent complication of the disease. This is a major concern for patients and their parents, and physicians are often asked about possible options to preserve fertility. Unfortunately, there are no recommendations on fertility preservation in this group. The unique pathophysiology of classic galactosemia with a severely reduced follicle pool at an early age requires an adjusted approach. In this article recommendations for physicians based on current knowledge concerning galactosemia and fertility preservation are made. Fertility preservation is only likely to be successful in very young prepubertal patients. In this group, cryopreservation of ovarian tissue is currently the only available technique. However, this technique is not ready for clinical application, it is considered experimental and reduces the ovarian reserve. Fertility preservation at an early age also raises ethical questions that should be taken into account. In addition, spontaneous conception despite POI is well described in classic galactosemia. The uncertainty surrounding fertility preservation and the significant chance of spontaneous pregnancy warrant counseling towards conservative application of these techniques. We propose that fertility preservation should only be offered with appropriate institutional research ethics approval to classic galactosemia girls at a young prepubertal age. BioMed Central 2013-07-16 /pmc/articles/PMC3718676/ /pubmed/23866841 http://dx.doi.org/10.1186/1750-1172-8-107 Text en Copyright © 2013 van Erven et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review van Erven, Britt Gubbels, Cynthia S van Golde, Ron J Dunselman, Gerard A Derhaag, Josien G de Wert, Guido Geraedts, Joep P Bosch, Annet M Treacy, Eileen P Welt, Corrine K Berry, Gerard T Rubio-Gozalbo, M Estela Fertility preservation in female classic galactosemia patients |
title | Fertility preservation in female classic galactosemia patients |
title_full | Fertility preservation in female classic galactosemia patients |
title_fullStr | Fertility preservation in female classic galactosemia patients |
title_full_unstemmed | Fertility preservation in female classic galactosemia patients |
title_short | Fertility preservation in female classic galactosemia patients |
title_sort | fertility preservation in female classic galactosemia patients |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718676/ https://www.ncbi.nlm.nih.gov/pubmed/23866841 http://dx.doi.org/10.1186/1750-1172-8-107 |
work_keys_str_mv | AT vanervenbritt fertilitypreservationinfemaleclassicgalactosemiapatients AT gubbelscynthias fertilitypreservationinfemaleclassicgalactosemiapatients AT vangolderonj fertilitypreservationinfemaleclassicgalactosemiapatients AT dunselmangerarda fertilitypreservationinfemaleclassicgalactosemiapatients AT derhaagjosieng fertilitypreservationinfemaleclassicgalactosemiapatients AT dewertguido fertilitypreservationinfemaleclassicgalactosemiapatients AT geraedtsjoepp fertilitypreservationinfemaleclassicgalactosemiapatients AT boschannetm fertilitypreservationinfemaleclassicgalactosemiapatients AT treacyeileenp fertilitypreservationinfemaleclassicgalactosemiapatients AT weltcorrinek fertilitypreservationinfemaleclassicgalactosemiapatients AT berrygerardt fertilitypreservationinfemaleclassicgalactosemiapatients AT rubiogozalbomestela fertilitypreservationinfemaleclassicgalactosemiapatients |